Over the past decade, great progress has been made in the field of immunotherapy, especially in the field of T cell therapy. Chimeric antigen receptor (CAR)-engineered T cell therapy is the most promising approach, which has shown remarkable ability in the elimination of a variety of tumors. While, as more studies focused on B cells, researchers have found that the engineered B cells also have great therapeutic potential in various diseases.
Based on advanced technology and years of research, Creative Biolabs has developed high-quality custom services covering the entire CAR-B therapy development process to best suit customer's technical, program, and budget requirements which can greatly assist customer's research, preclinical investigation, and clinical stage development.
Our CAR-B therapy development services harness the power of two main advantages:
Our one-stop CAR-B therapy development services include but not limited to:
A platform for the immunogenomic reprogramming of hybridoma cells, leading to the rapid generation of cell lines that both surface express and secrete full-length antibodies.
Creative Biolabs' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical study journey. We are committed to providing CAR-B development services to reduce the overall project development timeline for our clients. For further details, please don't hesitate to contact us and see how we can help you reach your clinical vision.
All services and products are only for lab research use, not for any clinical diagnosis or treatment.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE